niraparib
gsk,janssen
['prime', 'rectal']
 asco this year looks like has some real gems. we have n=12 6 month f/u cr being sent to nyt as miracle cure for rectal cancer; single arm cohort showing similar 5-yr recurrence as prime 2 and calgb being hailed as some astounding accomplishment 